Trautec Gets Funds to Scale Up Synthetic Recombinant Human Collagen for Skin Care & Aesthetics
Trautec has established large-scale production of type I, II, III, and XVII SRHC across five Chinese facilities. These innovations entered the U.S. market in 2022.
Source: cosmeticsandtoiletries.com